1.Analysis on the Level Measurement and Spatio-Temporal Characteristics of the New Quality Productivity of China's Medical and Health Service System
Zhishuo ZHANG ; Tao SHI ; Zengfa LIU ; Qian LI ; Yangdong CAO ; Lei NIE
Chinese Health Economics 2025;44(3):60-65
Objective:It aims to measure and analyze the spatial and temporal characteristics of the new quality productivity in China's healthcare service system,in order to reveal the current situation and existing problems of China's medical and health service system,and provide decision-making reference for further optimizing healthcare resource allocation,improving service efficiency and quality,and promoting the deep implementation of the"Healthy China"strategy.Methods:The new quality of productivity in China's healthcare service system from 2010 to 2019 was measured using the entropy weighted TOPSIS method,and the degree of association between each indicator and the new quality of productivity was explored using grey correlation analysis.The dynamic evolution of the new quality productivity in China's healthcare service system was explored using kernel density estimation,and the regional disparities were studied using the Dagum Gini coefficient.Results:The new quality productivity in China's healthcare service system showed an overall upward trend during the sample observation period.The efficiency of medical services,resource utilization level,human resource allocation,and financial input had a significant impact on the improvement of the new quality productivity in the healthcare service system.However,regional disparities constrain the overall development of China's healthcare service system.Conclusion:To further enhance the new quality productivity in China's healthcare service system and promote the equity,efficiency,and sustainable development of healthcare services,efforts should be made to strengthen talent training and recruitment,strengthen investment and upgrading of medical equipment;promote innovation in the medical and health service system;and enhance policy support and regulatory oversight.
2.Analysis on the Level Measurement and Spatio-Temporal Characteristics of the New Quality Productivity of China's Medical and Health Service System
Zhishuo ZHANG ; Tao SHI ; Zengfa LIU ; Qian LI ; Yangdong CAO ; Lei NIE
Chinese Health Economics 2025;44(3):60-65
Objective:It aims to measure and analyze the spatial and temporal characteristics of the new quality productivity in China's healthcare service system,in order to reveal the current situation and existing problems of China's medical and health service system,and provide decision-making reference for further optimizing healthcare resource allocation,improving service efficiency and quality,and promoting the deep implementation of the"Healthy China"strategy.Methods:The new quality of productivity in China's healthcare service system from 2010 to 2019 was measured using the entropy weighted TOPSIS method,and the degree of association between each indicator and the new quality of productivity was explored using grey correlation analysis.The dynamic evolution of the new quality productivity in China's healthcare service system was explored using kernel density estimation,and the regional disparities were studied using the Dagum Gini coefficient.Results:The new quality productivity in China's healthcare service system showed an overall upward trend during the sample observation period.The efficiency of medical services,resource utilization level,human resource allocation,and financial input had a significant impact on the improvement of the new quality productivity in the healthcare service system.However,regional disparities constrain the overall development of China's healthcare service system.Conclusion:To further enhance the new quality productivity in China's healthcare service system and promote the equity,efficiency,and sustainable development of healthcare services,efforts should be made to strengthen talent training and recruitment,strengthen investment and upgrading of medical equipment;promote innovation in the medical and health service system;and enhance policy support and regulatory oversight.
3.The Protective Effect of Guishu Blood-activating Capsules on Cerebral Ischemical Reperfusion Injury Model Rats
Shengchun WANG ; Jianfeng LI ; Mingyi LIU ; Zengfa CAO
China Pharmacy 2005;0(24):-
OBJECTIVE:To investigate the protective effect of Guishu blood-activating capsule on cerebral ischemical reperfusion injury of rats.METHODS:The cerebral embolism model rats were established,the rats were randomly divided into model group,nimodipine positive control group,Guishu blood-activating capsule(high,medium and low dosage groups,re?spectively)group and with another sham operation group established.Each group was administered intragastrically with water or the corresponding drugs,the cortexes and hippocampus tissues of the rats were divided into the injured side and the control side,the contents of aspartate(Asp),glutamate(Glu),malonaldehyde(MDA),lactate dehydrogenase(LD),the tumor necrosis factor?(TNF-?)and the activity of glutathione peroxidase(GSH-Px)were determined,the cerebral infarct size was determined by red tetrazoline staining method and the cerebral water content was determined by oven dry process.RE?SULTS:Compared with the model group,in one or several sub-groups of Guishu group,no marked change was noted in the content of Asp while that of the Glu in the injured side of the hippocampus tissues decreased significantly(P
4.Effects of Le Er Mai on apoptosis of hippocampus neuronal cells in anaphase of cerebral ischemic reperfusion injury in rats
Junqin WANG ; Shengchun WANG ; Jianfeng LI ; Zengfa CAO
Chinese Journal of Pathophysiology 1989;0(05):-
AIM:To investigate the effects and mechanism of Le Er Mai(LEM) on the apoptosis of hippocampus neuronal cells in the anaphase of cerebral ischemic reperfusion injury in rats.METHODS:A rat model of middle cerebral artery occlusion reperfusion(MCAO) was produced with the intraluminal filament.During reperfusion for 30 d after 2 h of ischemia,the TUNEL staining methods were used to detect apoptosis of hippocampus neuronal cells,and immunohistochemical technique were employed to examine the protein expression of Fas,Bax,caspase-3 and caspase-9 in the hippocampial.The gene expressions of fas,bax,caspase-3 and caspase-9 in hippocampial were examined by RT-PCR.RESULTS:After 2 h ischemia and 30 d reperfusion,compared with sham-operated group,TUNEL-positive staining cells and expression levels of Fas,Bax as well as caspase-3 and caspase-9 obviously increased,and the mRNA expressions of fas,bax,caspase-3 and caspase-9 in hippocampial markedly up-regulated in model group.Compared with model group,LEM at dose of 2.00 g/kg or 0.87 g/kg,and flunarizinum significantly reduced apoptosis and decreased the protein expressions of Fas,Bax,caspase-3 and caspase-9 in hippocampial,and down-regulated the mRNA expressions of fas,bax,caspase-3 and caspase-9(P
Result Analysis
Print
Save
E-mail